Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy.
FRONTIERS IN PHARMACOLOGY（2014）
关键词
diabetic nephropathy,chronic kidney disease,angiopoietin-like protein 4,N-acetyl-seryl-aspartyl-lysyl-proline,mineralocorticoid antagonist,PF-03882845,ERK5,MEK5
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要